Randy Brenner
General Counsel bei PARATEK PHARMACEUTICALS, INC.
Profil
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Aktive Positionen von Randy Brenner
| Unternehmen | Position | Beginn |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | General Counsel | 03.06.2015 |
Ehemalige bekannte Positionen von Randy Brenner
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.09.2011 |
| SHIRE | Corporate Officer/Principal | - |
Ausbildung von Randy Brenner
| Muhlenberg College | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
